Arshi, Banafsheh
Geurts, Sven
Tilly, Martijn J.
van den Berg, Marten
Kors, Jan A.
Rizopoulos, Dimitris
Ikram, M. Arfan
Kavousi, Maryam
Funding for this research was provided by:
Erasmus Medisch Centrum
Erasmus Universiteit Rotterdam
ZonMw
the Research Institute for Diseases in the Elderly
Ministerie van Onderwijs, Cultuur en Wetenschap
Ministerie van Volksgezondheid, Welzijn en Sport
European Commission
Municipality of Rotterdam
Article History
Received: 12 October 2021
Accepted: 24 January 2022
First Online: 21 February 2022
Declarations
:
: The Rotterdam Study has been approved by the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272–159521-PG). In addition, the Rotterdam Study has been entered into the Netherlands National Trial Register (NTR; ExternalRef removed) and the WHO International Clinical Trials Registry Platform (ICTRP; ExternalRef removed) under shared catalog number NTR6831. All participants provided written informed consent for participation and data collection from general practitioners and pharmacies.
: Not applicable.
: The authors declare that they have no competing interests.